Retatrutide appears to be a new treatment in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in research studies. By stimulating these https://lillinytg724045.dbblog.net/9393679/setmelanotide-a-promising-new-treatment-for-obesity